HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Says No Decision Reached Yet On Oxybenzone/Octinoxate Ban Petition

This article was originally published in The Rose Sheet

Executive Summary

According to industry, available scientific evidence regarding oxybenzone’s and octinoxate’s effects on coral does not support their removal from the OTC sunscreen drug monograph’s list of permitted UV filters, and FDA is fully compliant with federal environmental laws, contrary to the Center for Biological Diversity’s suggestions. FDA says the petition raises complex issues requiring extensive review.

You may also be interested in...



2018 In Review: California, Hawaii Pass Personal-Care Legislation Among 300+ State Bills Overall

On par with 2017, the Personal Care Products Council was tracking more than 300 state bills last year with potential implications for its members, including measures ultimately enacted by California and Hawaii to deter cosmetic animal testing and ban environmentally questionable sunscreens.

Key West Weighing Oxybenzone/Octinoxate Sunscreen Ban Per Hawaii’s Example

The Florida island city could be the next jurisdiction to prohibit the sale of oxybenzone- and octinoxate-containing sunscreens. Industry maintains that available science does not clearly link the ingredients to coral decline, with the Personal Care Products Council asking to present before the Key West City Commission at its January meeting.

Hawaii’s Sunscreen Ingredient Ban Is On The Books; To Industry, An Affront To Science

As in the case of plastic microbeads some four years ago, the personal-care industry finds itself in the position of having to reformulate potentially on a mass scale due to environmental rather than human safety concerns. And once again the legislation was driven in large part by shoddy science, industry says.

Related Content

Topics

UsernamePublicRestriction

Register

RS122565

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel